Negócios em Emersão  ·  Vamos Emergir?  ·  Cadastre-se e ganhe 50 REC de bonus
Notícias

Acompanhe as Notícias da Recifes

Fique por dentro das últimas novidades sobre tecnologia, negócios e empreendedorismo.

12 resultados carregados para "therapy"
Half of prostate cancer focal therapy use found to fall outside current guideline-supported groups
Half of prostate cancer focal therapy use found to fall outside current guideline-supported groups
Repercussão envolvendo fonte internacional chama atenção em Fitness.
New study closes critical gap in autism therapy for children
New study closes critical gap in autism therapy for children
Repercussão envolvendo fonte internacional chama atenção em Fitness.
CRISPR roadblocks: Scientists identify genes blocking gene therapy success
CRISPR roadblocks: Scientists identify genes blocking gene therapy success
Like a delivery driver navigating crowded city streets, a gene-therapy-toting lipid nanoparticle faces a gauntlet of potential detours on its journey toward a cell's nucleus.
Researchers develop mathematical measures to better personalize therapy for prostate cance
Researchers develop mathematical measures to better personalize therapy for prostate cance
Researchers at Moffitt Cancer Center have developed three mathematical biomarkers that may help physicians personalize adaptive therapy for prostate cancer by predicting treatment outcomes early in treatment. The biomarkers are specialized mathematical measures calculated from ro
Study ties estrogen-based menopausal hormone therapy to lower Alzheimer's risk
Study ties estrogen-based menopausal hormone therapy to lower Alzheimer's risk
Women on regimens of estrogen-only menopausal hormone therapy are at reduced risk of Alzheimer's disease, a study by Stanford Medicine investigators has found.
ASTRO updates guideline on radiation therapy for pancreatic cancer
ASTRO updates guideline on radiation therapy for pancreatic cancer
An updated clinical guideline from the American Society for Radiation Oncology (ASTRO) provides evidence-based recommendations on the use of radiation therapy to treat adult patients with pancreatic cancer.
In vivo CRISPR screen identifies gene edits that strengthen CAR-T therapy against solid tu
In vivo CRISPR screen identifies gene edits that strengthen CAR-T therapy against solid tu
For patients with blood cancers like leukemia and lymphoma, the immunotherapy known as CAR-T cell therapy can be lifesaving. Doctors remove a patient's immune cells, called T cells, engineer them in the lab to better recognize and attack cancer, and infuse them back into the bloo
Estrogen-only hormone therapy associated with lower risk of dementia
Estrogen-only hormone therapy associated with lower risk of dementia
Use of hormone therapy later in life was associated with a lower risk of developing dementia, according to a study published in Neurology.
Anti-Müllerian hormone predicts benefit of chemo + endocrine therapy in under-55s with breast cancer
Anti-Müllerian hormone predicts benefit of chemo + endocrine therapy in under-55s with breast cancer
Anti-Müllerian hormone (AMH) appears to predict the benefit of chemotherapy plus endocrine therapy (CET) versus ET alone in premenopausal women younger than 55 years with hormone receptor-positive/human epidermal growth factor receptor 2-negative breast cancer with a recurrence s
Personalized T-cell therapy eliminates detectable metastatic kidney tumor in adolescent after multiple relapses
Personalized T-cell therapy eliminates detectable metastatic kidney tumor in adolescent after multiple relapses
Researchers and physicians at the Hopp Children's Cancer Center Heidelberg (KiTZ) and other leading cancer centers report an exceptional treatment outcome in an adolescent with an advanced, treatment-resistant kidney tumor.
Cell-surface receptors guide antisense therapy to mutant KRAS in pancreatic cancer cells
Cell-surface receptors guide antisense therapy to mutant KRAS in pancreatic cancer cells
Antisense oligonucleotides (ASOs) have been proposed as a therapeutic approach to shut down the production of faulty proteins in a wide variety of diseases, including cancer. In a study published in the Journal of Cell Biology (JCB), researchers at the Cancer Research UK Scotland
Novo Nordisk and AWS bring agentic AI into drug discovery
Novo Nordisk and AWS bring agentic AI into drug discovery
Novo Nordisk is expanding its use of AWS artificial intelligence tools across drug discovery, including AI agents for target identification, therapy design, and research workflows. Under the agreement announced recently, AWS will become Novo Nordisk’s preferred cloud provider and